Literature DB >> 1887030

Metabolic and destructive brain disorders in children: findings with localized proton MR spectroscopy.

W Grodd1, I Krägeloh-Mann, U Klose, R Sauter.   

Abstract

The diagnostic potential of volume-selective proton magnetic resonance (MR) spectroscopy in vivo was evaluated in 20 children and young adults with various neurodegenerative brain disorders. All patients were examined with MR spectroscopy in conjunction with MR imaging of the brain on a whole-body imager at 1.5 T. Comparison of spectra in our patients with those of children with normal myelination (prominent signals from N-acetylaspartate [NAA], creatine/phosphocreatine, and choline) revealed a marked decrease of NAA in 12 of 17 patients with focal or generalized demyelination. In patients with Canavan disease, NAA signal intensity was markedly increased, but no choline signal was found. Increased signal intensity from lactate occurred in patients with Leigh disease, neuroaxonal dystrophy, Schilder disease, and Cockayne disease, which indicated a disturbed energy metabolism in the examined region. These results demonstrate that proton MR spectroscopy can be applied in a clinical environment to facilitate diagnosis of hereditary and acquired brain disorders in children.

Entities:  

Mesh:

Year:  1991        PMID: 1887030     DOI: 10.1148/radiology.181.1.1887030

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  24 in total

1.  MR imaging and MR spectroscopy in rhizomelic chondrodysplasia punctata.

Authors:  Angèle Viola; Sylviane Confort-Gouny; Jean-Philippe Ranjeva; Brigitte Chabrol; Charles Raybaud; Francisca Vintila; Patrick J Cozzone
Journal:  AJNR Am J Neuroradiol       Date:  2002-03       Impact factor: 3.825

2.  Radiological clue to diagnosis of Canavan disease.

Authors:  Priya Sreenivasan; K K Purushothaman
Journal:  Indian J Pediatr       Date:  2012-06-02       Impact factor: 1.967

Review 3.  Efficacy of proton magnetic resonance spectroscopy in neurological diagnosis and neurotherapeutic decision making.

Authors:  Alexander Lin; Brian D Ross; Kent Harris; Willis Wong
Journal:  NeuroRx       Date:  2005-04

4.  Neuroimaging in chronic fatigue syndrome.

Authors:  H Cope; A S David
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-05       Impact factor: 10.154

5.  Diagnostic and prognostic value of in vivo proton MR spectroscopy for Zellweger syndrome spectrum patients.

Authors:  H Rosewich; P Dechent; C Krause; A Ohlenbusch; K Brockmann; J Gärtner
Journal:  J Inherit Metab Dis       Date:  2016-08-03       Impact factor: 4.982

6.  Cerebral energy metabolism in isovaleric acidaemia.

Authors:  A K Lorek; J M Penrice; E B Cady; J V Leonard; J S Wyatt; R A Iles; S P Burns; E O Reynolds
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-05       Impact factor: 5.747

7.  Magnetic resonance spectroscopy (MRS) in the evaluation of pediatric brain tumors, Part II: Clinical analysis.

Authors:  S E Byrd; T Tomita; P S Palka; C F Darling; J P Norfray; J Fan
Journal:  J Natl Med Assoc       Date:  1996-11       Impact factor: 1.798

8.  Cranial ultrasound findings in aspartoacylase deficiency (Canavan disease).

Authors:  C Bührer; C Bassir; A von Moers; J Sperner; T Michael; D Scheffner; H J Kaufmann
Journal:  Pediatr Radiol       Date:  1993

9.  Magnetic resonance imaging in juvenile Canavan disease.

Authors:  P B Toft; R Geiss-Holtorff; M O Rolland; O Pryds; W Müller-Forell; E Christensen; W Lehnert; H C Lou; D Ott; J Hennig
Journal:  Eur J Pediatr       Date:  1993-09       Impact factor: 3.183

10.  One-methyl group metabolism in non-ketotic hyperglycinaemia: mildly elevated cerebrospinal fluid homocysteine levels.

Authors:  J L Van Hove; F Lazeyras; S H Zeisel; T Bottiglieri; K Hyland; H C Charles; L Gray; J Jaeken; S G Kahler
Journal:  J Inherit Metab Dis       Date:  1998-12       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.